Abstract
Only three to five percent of newly diagnosed cancer patients participate in clinical trials (Lara PN, 2001). We previously conducted a survey of U.S. lung cancer patients and found only 22% reported discussing clinical trial participation with their oncologist at the time of making treatment decisions (Fenton L, 2009). We hypothesized that a personalized navigation program could increase the amount of lung cancer patients initiating trial conversations with their oncologists and ultimately trial participation. Here we describe initial results from a pilot program, offering personalized, telephone-based clinical trial support to lung cancer patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
